Inhaled nitric oxide and intravenous magnesium sulphate for the treatment of persistent pulmonary hypertension of the newborn.
Singapore Med J 51(2):144-50 (2010) PMID 20358154
The aim of this study was to compare the response and survival rates of term infants with persistent pulmonary hypertension of the newborn (PPHN) on high frequency oscillatory ventilation (HFOV) treated with either inhaled nitric oxide (iNO) or intravenous magnesium sulphate (MgSO4).
Version: za2963e q8za6 q8zbb q8zcf q8zd8 q8ze9 q8zf2 q8zg2